Publication of 2 new articles implying SOLADIS

Two of the projects our team are working for our pharma clients have been published !

With those 2 articles, Soladis records its 95th and 96th publications.

« Basophils from allergic patients are neither hyper-responsive to activation signals nor hypo-responsive to inhibition signals. », a study published in the Journal of Allergy and Clinical Immunology.

and

« Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines. », published in The Journal of Infectious Diseases.

group.soladis-blanc

Soladis France (siège)
6-8 rue Bellecombe
69006 LYON - FRANCE
Tél: +33(0)4.72.83.86.70

Soladis Suisse
Gartenstrasse 22
CH-4052 Basel
Phone: +41(0)61.568.82.06

Soladis USA
185 Alewife Brook Pkwy, Unit 210
Cambridge, MA 02138-1100
Phone: +1.917.705.5342

Soladis Canada
545 King Street West, Suite 309,
TORONTO, ON M5V 1M1
Phone: +1.437.970.6462


NOUS CONTACTER

MENU

MENU

Suscribe to our newsletter